Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study on EUS-guided Portal Vein CTCs and Their Subtypes Combined With Multi-omics Detection for Early Warning of Pancreatic Cancer Recurrence and Metastasis

NCT07448376 is registered in ClinicalTrials.gov with Huazhong University of Science and Technology as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07448376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study on EUS-guided Portal Vein CTCs and Their Subtypes Combined With Multi-omics Detection for Early Warning of Pancreatic Cancer Recurrence and Metastasis
Lead sponsor
Huazhong University of Science and Technology
Phase
Observational
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
December 30, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

borderline resectable pancreatic cancer, ctcs, eus, liver metastases, pancreatic cancer, relapse, resectable pancreatic cancers